41
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE
“
MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS
”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
GLOBAL TRENDS AND NATIONAL APPROACHES TO THE TRAINING OF
CLINICAL PHARMACISTS
A.G. Ibragimova
1
S.K. Seidaliyeva
2
South Kazakhstan Medical Academy, Shymkent, Republic of Kazakhstan
e-mail: aygul_ibr@mail.ru
https://doi.org/10.5281/zenodo.17312344
Relevance:
Clinical pharmacy plays a key role in ensuring the rational use of medications and
reducing the incidence of drug-related complications, which, according to the WHO, account for up
to 10% of hospitalizations worldwide. International experience shows that the training of clinical
pharmacists is integrated into the educational programs of most countries, which contributes to
improving the quality of pharmacotherapy and patient safety. For Kazakhstan, the issue of integrating
clinical pharmacy into educational programs is particularly relevant in the context of the
modernization of the healthcare system.
Study Objective.
To conduct a comparative analysis of educational programs in the specialty
"Pharmacy" at universities in Kazakhstan in terms of their alignment with international approaches
to the training of clinical pharmacists.
Materials and Methods.
The study focused on the curricula of undergraduate, graduate, and
doctoral programs in Pharmacy. The methodology is based on a substantive analysis of disciplines
covering key areas: clinical pharmacology, pharmacotherapy, evidence-based medicine, good
practices (GCP, GVP), pharmacoeconomics, pharmacovigilance, and formulary systems.
Results.
A comparative analysis of educational programs revealed that the training of clinical
pharmacists at Kazakhstani universities is developing in stages, but has a number of specific features
and limitations.
Bachelor's degree curricula include individual elective courses, such as xenobiotic
biochemistry, hospital management, drug and medical device registration, and fundamentals of
clinical reasoning. These courses develop initial understanding of drug interactions with the div,
mechanisms of side effects, and drug interchangeability. However, the limited number of practical
modules restricts opportunities to develop clinical reasoning skills early in the program. Master's
degree programs include specialized disciplines such as evidence-based medicine, participation in
clinical trials, cost and effectiveness assessment of pharmacotherapy, personalized pharmacotherapy,
therapeutic drug monitoring, and formulary systems. These courses help students develop skills in
applying evidence in clinical practice and develop competencies in rational choice and economic
evaluation of pharmacotherapy. At the doctoral level, the emphasis shifts to research activities:
formulary policy development, risk analysis and management in drug therapy, preclinical studies,
regulatory aspects of drug registration, and antibiotic resistance. Doctoral programs train researchers
and experts capable of influencing national policy on the rational use of medicines.
Conclusions.
Educational programs implement a model for the gradual development of clinical
competence; however, gaps remain in practice-oriented training and the integration of international
standards. To improve the effectiveness of clinical pharmacist training, it is advisable to expand
practical modules, introduce uniform standards aligned with FIP and WHO recommendations, and
strengthen the research component of educational programs.
